SILEXION THERAPEUTICS CORP (SLXN) Operating cash flow 2023–2025
SILEXION THERAPEUTICS CORP (SLXN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.8MFY2025 · since FY2023: -$4.5M → -$10.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.8M | -28.9% |
| FY2024 | -$8.4M | -85.4% |
| FY2023 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice